HK1204992A1 - Topical ophthalmological pharmaceutical composition containing sunitinib - Google Patents
Topical ophthalmological pharmaceutical composition containing sunitinibInfo
- Publication number
- HK1204992A1 HK1204992A1 HK15105934.1A HK15105934A HK1204992A1 HK 1204992 A1 HK1204992 A1 HK 1204992A1 HK 15105934 A HK15105934 A HK 15105934A HK 1204992 A1 HK1204992 A1 HK 1204992A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pharmaceutical composition
- composition containing
- ophthalmological pharmaceutical
- topical ophthalmological
- containing sunitinib
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PK40512 | 2012-06-25 | ||
PCT/EP2012/062365 WO2013000917A1 (en) | 2011-06-28 | 2012-06-26 | Topical ophthalmological pharmaceutical composition containing regorafenib |
VE81612 | 2012-06-27 | ||
JOP20120170 | 2012-06-27 | ||
EP12198651 | 2012-12-20 | ||
PCT/US2013/044953 WO2013188283A1 (en) | 2012-06-12 | 2013-06-10 | Topical ophthalmological pharmaceutical composition containing sunitinib |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1204992A1 true HK1204992A1 (en) | 2015-12-11 |
Family
ID=49758933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15105934.1A HK1204992A1 (en) | 2012-06-25 | 2015-06-23 | Topical ophthalmological pharmaceutical composition containing sunitinib |
Country Status (7)
Country | Link |
---|---|
US (1) | US20150174096A1 (de) |
EP (1) | EP2858628A1 (de) |
JP (1) | JP2017512748A (de) |
CN (1) | CN104582685A (de) |
CA (1) | CA2876311A1 (de) |
HK (1) | HK1204992A1 (de) |
WO (1) | WO2013188283A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107278151A (zh) | 2014-12-15 | 2017-10-20 | 约翰霍普金斯大学 | 舒尼替尼制剂及其在治疗青光眼中的使用方法 |
CN108135737B (zh) | 2015-06-06 | 2021-11-05 | 拨云生物医药科技(广州)有限公司 | 用于治疗翼状胬肉的组合物和方法 |
TWI700085B (zh) | 2015-06-22 | 2020-08-01 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物的用途 |
WO2017083779A1 (en) | 2015-11-12 | 2017-05-18 | Graybug Vision, Inc. | Aggregating microparticles for therapy |
JP7079243B2 (ja) | 2016-06-02 | 2022-06-01 | エイディーエス セラピューティクス リミテッド ライアビリティ カンパニー | 緑内障手術の成功率を向上させるためにニンテダニブを使用する組成物および方法 |
EP3600324A4 (de) | 2017-03-23 | 2020-12-09 | Graybug Vision, Inc. | Arzneimittel und zusammensetzungen zur behandlung von augenkrankheiten |
WO2018182527A1 (en) * | 2017-03-30 | 2018-10-04 | National University Of Singapore | Method for treating inflammatory complications in eye diseases |
CN111201040A (zh) | 2017-05-10 | 2020-05-26 | 灰色视觉公司 | 用于医学疗法的缓释微粒及其悬浮液 |
KR20240028815A (ko) | 2022-08-25 | 2024-03-05 | 주식회사 스카이테라퓨틱스 | 약리 활성 물질의 신규 분자회합체 및 이를 포함하는 약학 조성물 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080011310A (ko) | 2005-05-10 | 2008-02-01 | 알콘, 인코퍼레이티드 | 폴록사머 또는 메록사폴 계면활성제 및 글리콜을유효성분으로 함유하는 현탁제, 안질환 치료용 의약의제조를 위한 그의 용도 |
MX2007014087A (es) * | 2005-05-12 | 2008-02-07 | Pfizer | Combinaciones y procedimientos para usar un compuesto de indolinona. |
CN101163473A (zh) * | 2005-05-12 | 2008-04-16 | 辉瑞大药厂 | 使用舒尼替尼苹果酸盐的抗癌组合疗法 |
JP2008543775A (ja) | 2005-06-08 | 2008-12-04 | ターゲジェン インコーポレーティッド | 眼の障害を治療するための方法および組成物 |
WO2007038453A2 (en) * | 2005-09-26 | 2007-04-05 | Advanced Ocular Systems Limited | Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation |
AU2006320535B2 (en) | 2005-11-29 | 2010-09-23 | Glaxosmithkline Llc | Treatment method |
JP2009521493A (ja) | 2005-12-23 | 2009-06-04 | アルコン,インコーポレイテッド | 眼への受容体チロシンキナーゼ阻害(RTKi)化合物の送達のための医薬製剤 |
WO2008027341A2 (en) | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
EP2098521A1 (de) * | 2008-03-06 | 2009-09-09 | Ratiopharm GmbH | Kristalline Formen von N-[2-(diethylamino)-Ethyl]-5-[Fluor-1,2-dihydro-2-oxo-3H-Indol-3-yliden)methyl]-2,4-Dimethyl-1H-Pyroll-3-Carboxamid und Verfahren zu ihrer Herstellung |
US8993615B2 (en) * | 2008-08-08 | 2015-03-31 | The Johns Hopkins University | Compositions and methods for treatment of neurodegenerative disease |
JP2012525415A (ja) | 2009-05-01 | 2012-10-22 | オプソテツク・コーポレイシヨン | 眼科疾患を処置または予防するための方法 |
MX2012000706A (es) | 2009-07-16 | 2012-06-01 | Glaxo Wellcome Mfg Pte Ltd | Metodo de tratamiento. |
EP2547323B1 (de) | 2010-03-17 | 2016-01-27 | Novaliq GmbH | Pharmazeutische zusammensetzung zur behandlung erhöhten intraokulardrucks |
-
2013
- 2013-06-10 WO PCT/US2013/044953 patent/WO2013188283A1/en active Application Filing
- 2013-06-10 EP EP13744855.1A patent/EP2858628A1/de not_active Withdrawn
- 2013-06-10 CN CN201380043571.7A patent/CN104582685A/zh active Pending
- 2013-06-10 CA CA2876311A patent/CA2876311A1/en not_active Abandoned
- 2013-06-10 JP JP2015518439A patent/JP2017512748A/ja not_active Revoked
- 2013-06-10 US US14/408,167 patent/US20150174096A1/en not_active Abandoned
-
2015
- 2015-06-23 HK HK15105934.1A patent/HK1204992A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2858628A1 (de) | 2015-04-15 |
CN104582685A (zh) | 2015-04-29 |
CA2876311A1 (en) | 2013-12-19 |
JP2017512748A (ja) | 2017-05-25 |
WO2013188283A1 (en) | 2013-12-19 |
WO2013188283A8 (en) | 2017-03-23 |
US20150174096A1 (en) | 2015-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1206297A1 (en) | Pharmaceutical compositions for combination therapy | |
PL3181122T3 (pl) | Kompozycja farmaceutyczna dazatynibu | |
ZA201501930B (en) | Pharmaceutical composition | |
HK1204992A1 (en) | Topical ophthalmological pharmaceutical composition containing sunitinib | |
HK1204564A1 (en) | Topical ophthalmological pharmaceutical composition containing axitinib | |
HK1204563A1 (en) | Topical ophthalmological pharmaceutical composition containing pazopanib | |
EP2832730A4 (de) | Mirabegronhaltige pharmazeutische zusammensetzung | |
HRP20190050T1 (hr) | Farmaceutski pripravci za kombinacijsku terapiju | |
IL266415A (en) | Innovative pharmaceutical composition | |
HK1197176A1 (en) | Topical ophthalmological pharmaceutical composition containing regorafenib | |
HK1210710A1 (en) | Pharmaceutical composition comprising rebamipide | |
ZA201505196B (en) | Topical ophthalmological pharmaceutical composition containing regorafenib | |
HK1204289A1 (en) | Topical ophthalmological pharmaceutical composition containing cediranib | |
ZA201502987B (en) | Pharmaceutical composition | |
EP2883546A4 (de) | Neue pharmazeutische zusammensetzung mit drei wirkstoffen mit differenzieller freisetzung | |
EP2897590A4 (de) | Pharmazeutische zusammensetzung | |
EP2851074A4 (de) | Analgetische pharmazeutische zusammensetzung | |
EP2851078A4 (de) | Pharmazeutische zusammensetzung | |
EP2930175A4 (de) | Neuartiges octahydropyridochinazolinderivat, pharmazeutische zusammensetzung damit sowie verwendungen des besagten derivats und der zusammensetzung | |
ZA201400751B (en) | Pharmaceutical composition | |
AU2012904295A0 (en) | Pharmaceutical composition | |
GB201221130D0 (en) | New pharmaceutical composition | |
PT2814473T (pt) | Composições farmacêuticas para terapia de combinação | |
GB201207701D0 (en) | New pharmaceutical composition | |
GB201207628D0 (en) | New pharmaceutical composition |